Recently, the role of TRPV1/TRPA1 activation in exacerbating asthma symptoms and its specific mechanisms have become increasingly clear, sparking interest among asthma drug development researchers in targeting TRPV1/TRPA1 antagonists. Here, TRPA1 is linked to asthma.